Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study

Christine Bodemer; G. Guillet; F. Cambazard; F. Boralévi; Stefania Ballarini; Christian Milliet; Paola Bertuccio; Carlo La Vecchia; Jean‐François Bach; Y. De Prost

doi:10.1371/journal.pone.0161555

Related publications

Article2013

Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway

Carmen Parola, Laura Salogni, Xenia Vaira, Sara Scutera, Paolo Somma, Valentina Salvi, Tiziana Musso, Giuseppe Tabbia, Marco Bardessono, Christian Pasquali, Alberto Mantovani, Silvano Sozzani, Daniela Bosisio

Article2013

Retrospective Analysis of the Relationship Between Infantile Seborrheic Dermatitis and Atopic Dermatitis

Alex Alexopoulos, Talia Kakourou, Irene Orfanou, Athina Xaidara, George Chrousos

Article2019

Zinc and atopic dermatitis: a systematic review and meta‐analysis

Nicola A. Gray, Ashar Dhana, Dan Joseph Stein, Nonhlanhla P. Khumalo

Article2005

Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.

Debra Breneman, Alan B. Fleischer, David Kaplan, Mark Lebwohl, Bruce Miller, David M. Pariser, Toivo Rist, Leonard J. Swinyer, Yin Liu, Valerie Foley

Article2019

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials

Andrew Alexis, Marta I. Rendon, Jonathan I. Silverberg, David M. Pariser, Benjamin Lockshin, Christopher Em Griffiths, Jamie Weisman, Andreas Wollenberg, Zhen Chen, John D. Davis, Meng Li, Laurent Eckert, Abhijit Gadkari, Brad Shumel, Ana B. Rossi, Neil M.H. Graham, Marius Ardeleanu